Lv63
2960 积分 2023-11-01 加入
Breaking the therapeutic ceiling in drug development in ulcerative colitis
22天前
已完结
Clinical outcome and peripheral CD4+ T profile in impending myasthenic crisis: A prospective cohort study
26天前
已完结
The Use of Real‐World Evidence for Regulatory Decisions in China
27天前
已完结
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
28天前
已完结
Pathophysiology of Inflammatory Bowel Diseases
28天前
已完结
Comparative efficacy of advanced therapies in biological-exposed ulcerative colitis – a network meta-analysis of randomized trials
1个月前
已完结
Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn’s disease
1个月前
已完结
The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms
1个月前
已完结
Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials
1个月前
已完结
Defining Radiological Healing in Perianal Fistulizing Crohn’s Disease: A TOpClass Global Expert Delphi Consensus
1个月前
已关闭
皖公网安备34019202002308
